Sage Therapeutics, Inc.
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid
Last updated:
Abstract:
This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and crystalline solid forms and compositions thereof. Also disclosed herein are methods of making crystalline solid forms of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
23 Aug 2017
Issue date:
1 Feb 2022